Brooks Automation Announces the Acquisition of Software Assets
August 22 2017 - 3:01PM
Brooks Automation, Inc. (Nasdaq:BRKS), announced today that it has
acquired certain assets from RURO, Inc., based in Frederick, MD.
These assets include the FreezerPro® web-based software which
enables access to information on stored samples from any location
on any device. As part of the acquisition, Brooks also entered an
exclusive license agreement to sell and distribute RURO’s
BioBankPro® software which integrates the functionality of
FreezerPro with other data sources, often from external sources or
instruments used in the workflow of sample-based research.
“The RURO software platform enhances our growing portfolio of
informatics solutions, providing customers with complete insight
into their samples and enabling them to accelerate their research,”
said Dusty Tenney, president of Brooks Life Sciences. “These
biorepository software tools are a natural fit into our life
sciences portfolio as informatics integrates our services,
consumables and infrastructure products by capturing comprehensive
sample management information for customers globally. We are taking
another step to enhance our customer’s sample workflow which
enables healthier and brighter tomorrows for patients.”
“Our laboratory freezer sample management software is a perfect
complement to Brooks Life Sciences,” said Vlad Lebedev, CEO RURO,
Inc., “integrating their comprehensive sample management solutions
with intuitive, reliable and secure software tools at customers
across multiple end markets.”
The acquisition is the latest addition to the growing portfolio
of Brooks Life Sciences’ products, services, and informatics.
FreezerPro and BioBankPro expand Brooks’ software offerings into a
full range of informatics solutions that will now address any size
laboratory, biobank or enterprise managing biological samples.
About Brooks Automation, Inc.
Brooks is a leading worldwide provider of automation and
cryogenic solutions for multiple markets including semiconductor
manufacturing and life sciences. Brooks’ technologies, engineering
competencies and global service capabilities provide customers
speed to market and ensure high uptime and rapid response, which
equate to superior value in their mission-critical controlled
environments. Since 1978, Brooks has been a leading partner to the
global semiconductor manufacturing market. Since 2011, Brooks has
applied its automation and cryogenics expertise to meet the sample
storage needs of customers in the life sciences industry. Brooks’
life sciences offerings include a broad range of products and
services for on-site infrastructure for sample management in
temperatures of ‑20°C to -150°C, as well as comprehensive outsource
service solutions across the complete life cycle of biological
samples including collection, transportation, processing, storage,
protection, retrieval and disposal. Brooks is headquartered in
Chelmsford, MA, with direct operations in North America, Europe and
Asia. For more information, visit www.brooks.com.
About RURO, Inc.
RURO, Inc. was founded in 2006 and is headquartered in the heart
of Maryland’s biotechnology corridor. RURO develops state of the
art computer software for research, biotechnological,
pharmaceutical, healthcare and government (homeland security)
laboratories in the US and worldwide. RURO is a web applications
leader, combining world-class innovation and industry experience so
individuals can use computer software in new ways and places. Their
recent line of biological applications is designed to increase the
productivity of scientific, biotech and pharmaceutical laboratories
while maintaining the highest level of security, versatility and
knowledge.
“Safe Harbor Statement” under Section 21E of the
Securities Exchange Act of 1934
Some statements in this release are forward-looking statements
made under Section 21E of the Securities Exchange Act of 1934.
These statements are neither promises nor guarantees but involve
risks and uncertainties, both known and unknown, that could cause
Brooks' financial and business results to differ materially from
our expectations. They are based on the facts known to management
at the time they are made. These forward-looking statements
include, but are not limited to, statements about the anticipated
benefits of the acquisition of the RURO assets. Factors that could
cause results to differ from our expectations include the
following: potential difficulties with the integration of the
assets into Brooks Life Science Systems and potential adverse
reactions or changes to business relationships resulting from
Brooks’ ownership of the acquired assets. In addition, actual
results are subject to other risks that relate more broadly to
Brooks’ overall business, including those that we have described in
our filings with the Securities and Exchange Commission, including
but not limited to our Annual Report on Form 10-K, current reports
on Form 8-K and our quarterly reports on Form 10-Q. As a result we
can provide no assurance that our future results will not be
materially different from those projected. Brooks expressly
disclaims any obligation or undertaking to release publicly any
updates or revisions to any such statement to reflect any change in
our expectations or any change in events, conditions or
circumstances on which any such statement is based. Brooks
undertakes no obligation to update the information contained in
this press release.
CONTACTS: Lynne Yassemedis Brooks Automation 978.262.2400
lynne.yassemedis@brooks.com
John Mills Senior Managing Director ICR, LLC 646.277.1254
john.mills@icrinc.com
Brooks Automation (NASDAQ:BRKS)
Historical Stock Chart
From Apr 2024 to May 2024
Brooks Automation (NASDAQ:BRKS)
Historical Stock Chart
From May 2023 to May 2024